CAS: 1215115-03-9
| Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
|---|---|---|---|---|
 | (2E)-3-[5-(4-tert-Butylbenzenesulfonamido)-1-benzothiophen-2-yl]-N-hydroxyprop-2-enamide REF: 3D-QYB11503CAS: 1215115-03-9 | Min. 95% | A consultar | Sex 27 Dez 24 |
 | KH-3 REF: TM-T62398CAS: 1215115-03-9 | - - - | 1.158,00 €~2.279,00 € | Qua 15 Jan 25 |
![(2E)-3-[5-(4-tert-Butylbenzenesulfonamido)-1-benzothiophen-2-yl]-N-hydroxyprop-2-enamide](https://static.cymitquimica.com/products/3D/thumb/QYB11503.jpg)
(2E)-3-[5-(4-tert-Butylbenzenesulfonamido)-1-benzothiophen-2-yl]-N-hydroxyprop-2-enamide
CAS:1215115-03-9
Please enquire for more information about (2E)-3-[5-(4-tert-Butylbenzenesulfonamido)-1-benzothiophen-2-yl]-N-hydroxyprop-2-enamide including the price, delivery time and more detailed …
Pureza:
Min. 95%
Peso molecular:
430.5 g/mol
Ref: 3D-QYB11503
| 25mg | A consultar | ||
| 250mg | A consultar |
Entrega estimada em Estados Unidos, Sexta-feira 27 de Dezembro de 2024
KH-3
CAS:1215115-03-9
KH-3: HuR inhibitor, IC50 0.35 μM, halts cell growth, blocks HuR-FOXQ1 mRNA, curbs breast cancer …
Fórmula:
C21H22N2O4S2
Cor e Forma:
Solid
Peso molecular:
430.54
Ref: TM-T62398
| 25mg | 1.158,00 € | ||
| 50mg | 1.505,00 € | ||
| 100mg | 2.279,00 € |
Entrega estimada em Estados Unidos, Quarta-feira 15 de Janeiro de 2025
